🧠 Food for thought

Implications, context, and why it matters.

Nourish’s funding fits a telehealth model built on insurer reimbursement

• Nourish says it reaches more than 200 million covered lives in the US through insurer partnerships. That moves growth away from costly direct-to-consumer marketing, which weighs on many digital health startups.
• Insurer contracts give Nourish a scalable route to patient acquisition. They also position the company as a partner in managing healthcare costs. That sets it apart from a consumer wellness app.
• Its network of more than 10,000 registered dietitians is a barrier to entry. Insurance contracts can drive large demand, and few new rivals could build that clinical workforce quickly.

GLP-1 drugs open a market for clinician-supported digital health

• Nourish offers lab testing and GLP-1 medication management services. GLP-1 drugs are medicines used to treat obesity and diabetes, and they often need diet and lifestyle support to work over time.
• That setup moves dietitians beyond general wellness coaching into specialist support for patients on expensive therapies. It also creates reimbursable demand for their services.
• The planned investment in AI tools suggests support for the clinical network. It could help dietitians manage more patients and strengthen a hybrid care model that insurers may fund to keep costs down.